Are new weight loss drugs an answer or problem?
World of DTC Marketing
JULY 17, 2022
Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025. Payers also face hurdles, so patients must obtain permission before filling a prescription. One Maryland pharmacist told me she had seen many prescriptions for Wegovy, none of which had ever come back after being sent for authorization. .
Let's personalize your content